TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.07
Delayed Data
As of Feb 27
 -0.27 / -5.06%
Today’s Change
3.42
Today|||52-Week Range
9.01
+13.93%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.34
Today’s open5.41
Day’s range-- - --
Volume1,786,100
Average volume (3 months)1,005,240
Market cap$860.3M
Dividend yield--
Data as of 02/27/2015

Growth & Valuation

Earnings growth (last year)+42.11%
Earnings growth (this year)-59.09%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+129.85%
P/E ratioNM
Price/Sales75.74
Price/Book13.44

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-1.16-4.09%
RGENRepligen Corp-0.49-1.87%
FOLDAmicus Therapeutics ...-0.03-0.34%
EPZMEpizyme Inc-0.08-0.34%
Data as of 02/27/2015

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$8.8M
Annual profit (last year)-$28.4M
Net profit margin-323.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account